Bimekizumab in hidradenitis suppurativa: a valid and effective emerging treatment

Clin Exp Dermatol. 2023 Oct 25;48(11):1272-1274. doi: 10.1093/ced/llad229.

Authors

Elisa Molinelli¹, Daisy Gambini¹, Andrea Maurizi¹, Edoardo De Simoni¹, Claudia Sapigni¹, Sara Belleggia¹, Giulio Rizzetto¹, Annamaria Offidani¹, Oriana Simonetti¹

Affiliation

¹ Dermatological Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, Ancona, Italy.

PMID: 37403675
DOI: 10.1093/ced/llad229

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized
Hidradenitis Suppurativa* / drug therapy
Humans
Treatment Outcome

Substances

bimekizumab
Antibodies, Monoclonal, Humanized